TABLE 5.
CAMARADES evaluation results.
(A) | (B) | (C) | (D) | (E) | (F) | (G) | (H) | (I) | (J) | Total | |
---|---|---|---|---|---|---|---|---|---|---|---|
Chen Jie | ✔ | ✔ | ✔ | ✔ | 4 | ||||||
Chen Ming | ✔ | 1 | |||||||||
He Yan | ✔ | ✔ | 2 | ||||||||
Jiang Huihui | ✔ | ✔ | ✔ | ✔ | 4 | ||||||
Li Jingxian | ✔ | ✔ | 2 | ||||||||
Lin Jun | ✔ | 1 | |||||||||
Liu Lixing | ✔ | ✔ | ✔ | 3 | |||||||
Liu Yinhua | ✔ | ✔ | ✔ | 3 | |||||||
Meng Lanqing | ✔ | ✔ | ✔ | 3 | |||||||
Sun Xiaoqing | ✔ | 1 | |||||||||
Tang Jingshu | ✔ | ✔ | ✔ | 3 | |||||||
Wang Jiehua | ✔ | 1 | |||||||||
Wang Ping | ✔ | ✔ | ✔ | 3 | |||||||
Zhang Yongquan | ✔ | ✔ | 2 |
(A) Peer-reviewed publications; (B) randomization of subjects into treatment groups; (C) assessment of dose-response relationship; (D) blinded assessment of behavioral outcome; (E) monitoring of physiological parameters such as body temperature; (F) calculation of necessary sample size to achieve sufficient power; (G) statement of compliance with animal welfare regulations; (H) avoidance of anesthetic agents with marked intrinsic neuroprotective properties; (I) statement of potential conflict of interests; (J) use of a suitable animal model.